Trial reportParkinsonism & related disorders2014
The cognition and emotional well-being indices of the Parkinson's disease questionnaire-39: what do they really measure?
Trial report in Parkinsonism & related disorders, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Effects of different exercises on motor and non-motor abilities in patients with Parkinson disease-a network meta-analysis of randomized controlled trials.Frontiers in physiology · 2026Pooled it
- A systematic review of the associations between sedentary behavior, physical inactivity, and non-motor symptoms of Parkinson's disease.PloS one · 2024Pooled it
- Effect of dual-task interference on upper extremity motor experience with Parkinson's disease motor effect of dual-task in Parkinson's disease.BMC neurology · 2025Trial
- Trial
- Study on influencing factors of anxiety symptoms and its association with nutritional condition in elderly heart failure patients.Frontiers in nutrition · 2026Article
- Hippocampal functional imaging-derived radiomics features for diagnosing cognitively impaired patients with Parkinson's disease.BMC neuroscience · 2025Article
- Concealment of Parkinsons disease prevalence and impact on health and quality of life.Scientific reports · 2025Article
- Anticholinergic Medication Burden and Cognitive Subtypes in Parkinson's Disease without Dementia.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2024Article
- Article
- Using network analysis to explore the validity and influential items of the Parkinson's Disease Questionnaire-39.Scientific reports · 2023Article
- Predictors of health-related quality of life in Parkinson's disease: the impact of overlap between health-related quality of life and clinical measures.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022Article
- Dysosmia Is a Predictor of Motor Function and Quality of Life in Patients with Parkinson's Disease.Journal of personalized medicine · 2022Article
- Effectiveness and safety of herbal medicine Ukgansan for clinical symptoms in Parkinson's disease: A pilot, randomized, assessor-blinded clinical trial.Frontiers in neurology · 2022Article
- Impact of Mild Cognitive Impairment on Quality of Life in Young and Typical Onset Parkinson's Disease.Movement disorders clinical practice · 2022Article
- Measuring quality of life with the Parkinson's Disease Questionnaire-39 in people with cognitive impairment.PloS one · 2022Article
- Mapping Actuarial Criteria for Parkinson's Disease-Mild Cognitive Impairment onto Data-Driven Cognitive Phenotypes.Brain sciences · 2021Article
- Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown.BMC neurology · 2021Article
- Impact of subthreshold depression on health-related quality of life in patients with Parkinson's disease based on cognitive status.Health and quality of life outcomes · 2021Observational
- The UF Deep Brain Stimulation Cognitive Rating Scale (DBS-CRS): Clinical Decision Making, Validity, and Outcomes.Frontiers in human neuroscience · 2020Article
- Long-term Parkinson's disease quality of life after staged DBS: STN vs GPi and first vs second lead.NPJ Parkinson's disease · 2020Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
introductionThe Parkinson's disease questionnaire-39 (PDQ-39) is a common measure of health related quality of life (HRQoL) that is widely used with Parkinson disease (PD) patients. Previous evidence suggests that the PDQ-39 reflects at least 8 dimensions (i.e., Emotion, Cognitions, Mobility, etc). To date, little research has examined the external/convergent validity of the Cognitions and Emotional Well-being domains of the PDQ-39.
methodsA convenience sample of 303 PD patients underwent a comprehensive multi-domain neuropsychological evaluation, including tests of execution function, episodic verbal memory, processing speed, language and working memory, as well as completing measures of depression, apathy, state and trait anxiety and HRQoL (PDQ-39). Hierarchical regressions were conducted in order to examine the relationship between scores on neuropsychological tests and the Cognitions index, as well as mood measures and the Emotional Well-being index of the PDQ-39.
resultsNeuropsychological test performance did not account for a significant amount of variance in the PDQ-39 Cognitions index scores. Instead, it was depression that significantly contributed to the Cognitions index, above and beyond neuropsychological performance. The PDQ-39 Emotional Well-being index was also related to mood measures, primarily depression and trait anxiety.
conclusionsThe PDQ-39 Cognition index may be more related to mood functioning, as opposed to cognitive functioning, and should not be considered a "proxy" for cognitive functioning. Future studies are needed to better explain the construct of this index.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.